Acorda Therapeutics Inc (ACOR.O)

ACOR.O on Nasdaq

37.26USD
1 Aug 2013
Price Change (% chg)

$-0.71 (-1.87%)
Prev Close
$37.97
Open
$37.97
Day's High
$38.43
Day's Low
$36.00
Volume
510,666
Avg. Vol
340,436
52-wk High
$40.87
52-wk Low
$21.33

ACOR.O

Chart for ACOR.O

About

Acorda Therapeutics, Inc. (Acorda) is a commercial-stage biopharmaceutical company. The Company is engaged in the identification, development and commercialization of novel therapies that improve neurological function in people with multiple sclerosis (MS), spinal cord injury (SCI), and other disorders of the nervous system.... (more)

Overall

Beta: 0.85
Market Cap (Mil.): $1,540.29
Shares Outstanding (Mil.): 40.57
Dividend: --
Yield (%): --

Financials

  ACOR.O Industry Sector
P/E (TTM): 10.57 47.13 37.76
EPS (TTM): 3.59 -- --
ROI: 37.79 -2.58 18.76
ROE: 47.80 -2.66 19.59
Search Stocks

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Wright Reports
$472.00
Provider: Stock Traders Daily
$58.00
Provider: Stock Traders Daily
$495.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks